When was Odin Vision founded?

Odin Vision was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Odin Vision located?

Odin Vision is headquartered in London, United Kingdom.

Which legal entities is Odin Vision associated with?

Odin Vision is associated with Odin Medical Ltd.

How many employees does Odin Vision have?

As of Sep 30, 2026, the latest employee count at Odin Vision is 53.

Is Odin Vision a funded company?

Odin Vision is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 12, 2019.

When was the latest funding round of Odin Vision?

Odin Vision's latest funding was a $***** Seed round on May 01, 2019, with participation from 2 investors.

Where does Odin Vision rank among its competitors?

Odin Vision ranks 115th amongst 404 active competitors, of which 133 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was 4baseCare, which secured an undisclosed amount in Jul, 2026.

Who are the top competitors of Odin Vision?

Odin Vision's top competitors include Caris Life Sciences, Geneoscopy and 4baseCare. Among them, 4baseCare secured the most recent funding round in July, 2026.

Odin Vision - 2026 Company Profile, Team, Funding, Competitors & Financials

Odin Vision is an acquired company based in London (United Kingdom), founded in 2019. It operates as a Provider of AI-based colon cancer detection platform. Odin Vision has raised an undisclosed amount in funding from London Co-Investment Fund and UCL Technology Fund. The company has 404 active competitors, including 133 funded and 85 that have exited. Its top competitors include companies like Caris Life Sciences, Geneoscopy and 4baseCare.

Company Details

Odin Vision is developing AI-based applications for endoscopic procedures. The company is developing a colon cancer detection platform using deep learning technology. The platform will analyze the images taken by the endoscopic camera during polyps assessment.

Website: odin-vision.com/en_gb/
Social
Email ID: *****@odin-vision.com

Key Metrics

Founded Year

2019

Location

London, United Kingdom

Stage

Acquired

Latest Funding Round

Seed, May 01, 2019, $*****

Investors

London Co-Investment Fund & 18 more

Ranked

115^th among 404 active competitors

Employee Count

53 as on Sep 30, 2026

Similar Companies

OpenEvidence & 3387 more

Exit Details

Acquired by Olympus (Dec 20, 2022)

View Odin Vision's full profile

Odin Vision is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Odin Medical Ltd CIN: 11563083 , United Kingdom, Active	Aug 10, 2018	-	12 (As on Sep 30, 2021)

Odin Vision got acquired by Olympus on Dec 20, 2022.

Click here to take a look at Odin Vision's acquisition in detail

Odin Vision has raised funding over 3 rounds. Its first funding round was on Jan 12, 2019. Its latest funding round was a Seed round on May 01, 2019 for $*****. 2 investors participated in its latest round. Odin Vision has 10 institutional investors and 9 angel investors.

Here is the list of recent funding rounds of Odin Vision:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2019	3313273	Seed	1425365	8040619	3348091	8061818
May 01, 2019	6754122	Grant (prize money)	5251021	7964159	6551959	Gov & 2 more
Jan 12, 2019	5197319	Grant (prize money)	8710279	7382381	1371455	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Odin Vision's funding rounds and investors

Odin Vision's employee count trend

Odin Vision has 53 employees as of Sep 26. Here is Odin Vision's employee count trend over the years:

Uncover Odin Vision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Odin Vision include Caris Life Sciences, Geneoscopy and 4baseCare. Here is the list of Top 10 competitors of Odin Vision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	71/100
2nd	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
3rd	4baseCare 2018, Bengaluru (India), Series B	Provider of precision oncology solutions, including genomic testing and digital health	$25.9M	Tremis Consultancy, Yali Capital & 41 others	67/100
4th	Freenome Health 2014, United States, Series E	Provider of a deep learning platform for detecting circulating cancer-related markers	$1.35B	Perceptive Advisors, RA Capital Management ... & 65 others	66/100
5th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Novartis & 10 others	66/100
6th	NeoGenomics 2002, Fort Myers (United States), Public	Provider of cancer genetic diagnostic services	-	Ranger Investments, Aspen Capital & 1 others	63/100
7th	Deep Genomics 2014, Toronto (Canada), Series C	AI-powered platform for RNA biology to accelerate genetic therapy discovery	$238M	SoftBank Vision Fund, True Ventures & 16 others	62/100
8th	UniQure 1998, Amsterdam (Netherlands), Public	Developer of gene-based therapies for patients with genetic or acquired diseases	$111M	Gilde Healthcare, Advent Life Sciences & 11 others	62/100
9th	Regulus Therapeutics 2007, San Diego (United States), Acquired	Innovative medicines company reimagining medicine to improve and extend people’s lives	$35M	Ionis Pharmaceuticals, Alnylam & 8 others	62/100
10th	Personalis 2011, Menlo Park (United States), Acquired	Provider of genomic sequencing and diagnosis software for the healthcare industry	$87.3M	Abingworth, Lightspeed Venture Partners & 5 others	61/100
115th	Odin Vision 2019, London (United Kingdom), Acquired	Provider of AI-based colon cancer detection platform	-	UCL Technology Fund, ESA & 17 others	43/100